GRI Bio is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio’s therapies are designed to target ...
ST. LOUIS--(BUSINESS WIRE)--Pivot Bio, Inc., a sustainable agriculture company, solidified its leadership in the development of breakthrough crop nutrition technologies at the 2023 International ...
~ Presentation to highlight the potential of Gennao’s proprietary, non-viral gene monoclonal antibody (GMAB) platform technology to systemically target medulloblastoma in vivo ~ ~ The GMAB platform ...
The main theme of the Conference is to bring lessons learned from past experiences to drive future advancements in nuclear installation safety, which implies covering the wide range of nuclear safety ...
LA JOLLA, CA, April 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) ("GRI Bio” or the "Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T ("NKT”) cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback